Avantax Advisory Services Inc. Boosts Stake in Stryker Co. (NYSE:SYK)

Avantax Advisory Services Inc. raised its position in shares of Stryker Co. (NYSE:SYK) by 4.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,273 shares of the medical technology company’s stock after acquiring an additional 887 shares during the period. Avantax Advisory Services Inc.’s holdings in Stryker were worth $7,659,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in SYK. Assetmark Inc. grew its position in Stryker by 30.7% during the third quarter. Assetmark Inc. now owns 1,013 shares of the medical technology company’s stock valued at $366,000 after acquiring an additional 238 shares during the period. Harbour Investments Inc. boosted its position in shares of Stryker by 4.2% in the third quarter. Harbour Investments Inc. now owns 6,330 shares of the medical technology company’s stock worth $2,287,000 after buying an additional 256 shares during the period. GSA Capital Partners LLP purchased a new stake in shares of Stryker in the third quarter worth about $362,000. Aigen Investment Management LP purchased a new stake in shares of Stryker in the third quarter worth about $493,000. Finally, Victory Capital Management Inc. boosted its position in shares of Stryker by 5.6% in the third quarter. Victory Capital Management Inc. now owns 163,822 shares of the medical technology company’s stock worth $59,182,000 after buying an additional 8,745 shares during the period. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insider Transactions at Stryker

In related news, Director Allan C. Golston sold 2,458 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total value of $941,586.06. Following the completion of the transaction, the director now directly owns 14,895 shares of the company’s stock, valued at $5,705,827.65. This represents a 14.16 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Ronda E. Stryker sold 201,392 shares of the stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $392.24, for a total value of $78,993,998.08. Following the completion of the transaction, the director now directly owns 3,642,075 shares of the company’s stock, valued at $1,428,567,498. This trade represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 5.90% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on SYK. Stifel Nicolaus upped their target price on Stryker from $400.00 to $440.00 and gave the stock a “buy” rating in a research report on Wednesday, January 29th. JPMorgan Chase & Co. upped their target price on Stryker from $420.00 to $445.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 29th. JMP Securities reaffirmed a “market perform” rating on shares of Stryker in a research report on Tuesday, February 18th. Morgan Stanley upgraded Stryker from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $370.00 to $445.00 in a research note on Monday, December 2nd. Finally, Argus set a $450.00 price target on Stryker in a research note on Monday, February 3rd. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, Stryker has an average rating of “Moderate Buy” and a consensus target price of $421.90.

Stryker Stock Down 0.0 %

Shares of Stryker stock opened at $363.79 on Friday. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 0.59. The business’s 50 day simple moving average is $382.87 and its 200-day simple moving average is $373.26. The stock has a market capitalization of $138.81 billion, a price-to-earnings ratio of 46.88, a PEG ratio of 2.93 and a beta of 0.95. Stryker Co. has a twelve month low of $314.93 and a twelve month high of $406.19.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, topping analysts’ consensus estimates of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter in the previous year, the business posted $3.46 EPS. Equities research analysts forecast that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be given a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.92%. The ex-dividend date of this dividend is Monday, March 31st. Stryker’s payout ratio is 43.30%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.